Altshuler Shaham’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,541
| Closed | -$1.53M | – | 337 |
|
|
2024
Q2 | $1.53M | Buy |
16,541
+8,286
| +100% | +$734K | 0.05% | 38 |
|
|
2024
Q1 | $789K | Sell |
8,255
-10,386
| -56% | -$872K | 0.03% | 46 |
|
|
2023
Q4 | $1.42M | Buy |
18,641
+7,886
| +73% | +$549K | 0.08% | 29 |
|
|
2023
Q3 | $745K | Buy |
10,755
+10,422
| +3,130% | +$838K | 0.02% | 54 |
|
|
2023
Q2 | $31.4K | Buy |
+333
| New | +$28.9K | ﹤0.01% | 220 |
|
|
2022
Q3 | – | Sell |
-301
| Closed | -$29K | – | 487 |
|
|
2022
Q2 | $29K | Sell |
301
-498
| -62% | -$51.6K | ﹤0.01% | 322 |
|
|
2022
Q1 | $94K | Sell |
799
-276
| -26% | -$31K | ﹤0.01% | 271 |
|
|
2021
Q4 | $139K | Buy |
1,075
+5
| +0.5% | +$583 | ﹤0.01% | 293 |
|
|
2021
Q3 | $122K | Sell |
1,070
-68
| -6% | -$7.76K | ﹤0.01% | 297 |
|
|
2021
Q2 | $118K | Buy |
+1,138
| New | +$107K | ﹤0.01% | 297 |
|
|
2021
Q1 | – | Sell |
-423
| Closed | -$39K | – | 487 |
|
|
2020
Q4 | $39K | Buy |
423
+116
| +38% | +$9.62K | ﹤0.01% | 304 |
|
|
2020
Q3 | $25K | Buy |
+307
| New | +$24K | ﹤0.01% | 307 |
|
|
2020
Q2 | – | Sell |
-210
| Closed | -$14K | – | 430 |
|
|
2020
Q1 | $14K | Sell |
210
-5,856
| -97% | -$422K | ﹤0.01% | 258 |
|
|
2019
Q4 | $472K | Buy |
6,066
+5,583
| +1,156% | +$436K | 0.01% | 107 |
|
|
2019
Q3 | $35K | Buy |
483
+306
| +173% | +$21.5K | ﹤0.01% | 189 |
|
|
2019
Q2 | $11K | Sell |
177
-150
| -46% | -$9.07K | ﹤0.01% | 277 |
|
|
2019
Q1 | $21K | Buy |
327
+177
| +118% | +$10.1K | ﹤0.01% | 172 |
|
|
2018
Q4 | $8K | Buy |
+150
| New | +$7.59K | ﹤0.01% | 192 |
|
Other funds holding EW
